Guest blog by Estelle Roger, Precision for Medicine
Research & Development (R&D) Tax Credits are available to pharma and biotechs to incentivize drug development and clinical research in countries around the world
In this article, we will discuss the United Kingdom’s R&D tax credit program, which is part of its post-Brexit strategy to boost innovation in drug development within its borders. First, a bit of information about Precision for Medicine. We are more than just a Contract Research Organization and have a comprehensive suite of capabilities to support the spectrum…
Guest Blog Post by Sura Hussein, Senior Business Development Manager, London & Partners
Reflecting on the fabulous One Nucleus event last week #Genesis2022 I wanted to share some notes on the panel discussing the key ingredients for a successful Life sciences cluster.
The stage was an upbeat debate with the playful title which was Cambridge UK vs Cambridge MA / USA.
The Debaters were: Catherine Stace, Domainex, Max Bryan, Bidwells, John McCafferty, Maxion Therapeutics, Nick Foster, Metrion Biosciences, Jiahao Huang, Nuclera – chaired by Mike Ward, Clarivate
Taking that I am bias for…
Guest article by RSM UK
There is growing consensus that the UK economy will remain in recession through much of 2023.
We asked our panel of middle market business leaders how prepared they feel for the oncoming difficulties.
Explore the findings
If you would like to submit a guest blog or article, please contact natalie@onenucleus.com
Guest article from RSM UK
The UK's healthcare sector is battling crippling workforce shortages and an unprecedented NHS backlog. Digital innovations will be essential to solving the most pressing health challenges of our generation.
Our healthcare experts examine how harnessing digitalisation and collaboration between the private and public sector can help tackle these key challenges. Read the article
If you are interested in submitting a guest blog or article on the One Nucleus website, please contact natalie@onenucleus.com